[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100311346":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":16,"locations":22,"responsibleParty":39,"collaborators":7,"id":43,"slug":44,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":47,"acronym":7,"eligibilityCriteria":48,"healthyVolunteers":45,"sex":49,"minAge":7,"maxAge":7,"enrollmentInfo":50,"targetDuration":7,"studyType":53,"phases":7,"briefSummary":54,"conditions":55,"keywords":83,"overallStatus":25,"whyStopped":7,"lastUpdateSubmitDate":98,"lastUpdatePostDateStruct":99,"startDateStruct":102,"completionDateStruct":104,"leadSponsor":106,"locationsCount":107},{"fullName":5,"class":6},"University of Pittsburgh","OTHER",null,[9,12],{"type":6,"name":10,"description":11,"armGroupLabels":7,"otherNames":7},"Palliative Care","Collecting information about the natural progression of these diseases",{"type":13,"name":14,"description":15,"armGroupLabels":7,"otherNames":7},"BIOLOGICAL","Hematopoetic Stem Cell Transplantation","Following patients who have received HSCT as part of their clinical care.",[17],{"name":18,"role":19,"phone":20,"phoneExt":7,"email":21},"Deepa Rajan, MD","CONTACT","412-692-8388","rajands@upmc.edu",[23],{"facility":24,"status":25,"city":26,"state":27,"zip":28,"country":29,"countryCode":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"UPMC Children's Hospital of Pittsburgh","RECRUITING","Pittsburgh","Pennsylvania","15224","United States","US",{"type":32,"coordinates":33},"Point",[34,35],-79.99589,40.44062,{"lat":35,"lon":34},[38],{"name":18,"role":19,"phone":20,"phoneExt":7,"email":21},{"type":40,"investigatorFullName":41,"investigatorTitle":42,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Deepa Soundara Rajan","Associate Professor","100311346","longitudinal-study-of-neurodegenerative-disorders-100311346",false,"NCT03333200","Longitudinal Study of Neurodegenerative Disorders","Inclusion Criteria:\n\n* Any patient with a genetic neurodegenerative disorder\n\nExclusion Criteria:\n\n* none","ALL",{"count":51,"type":52},1500,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to understand the course of rare genetic disorders that affect the brain. This data is being analyzed to gain a better understanding of the progression of the rare neurodegenerative disorders and the effects of interventions.",[56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82],"MLD","Krabbe Disease","ALD","MPS I","MPS II","MPS III","Vanishing White Matter Disease","GM3 Gangliosidosis","PKAN","Tay-Sachs Disease","NP Deficiency","Osteopetrosis","Alpha-Mannosidosis","Sandhoff Disease","Niemann-Pick Diseases","MPS IV","Gaucher Disease","GAN","GM1 Gangliosidoses","Morquio Disease","S-Adenosylhomocysteine Hydrolase Deficiency","Batten Disease","Pelizaeus-Merzbacher Disease","Leukodystrophy","Lysosomal Storage Diseases","Purine Nucleoside Phosphorylase Deficiency","Multiple Sulfatase Deficiency Disease",[84,85,86,87,88,89,90,91,92,93,94,95,96,97],"Pediatric","Rare","Neurodegenerative","Genetic","Neurodevelopment","Brain","MRI","Biorepository","NDRD","Longitudinal","Cognitive","Motor","Language","Adaptive behavior","2026-02-04",{"date":100,"type":101},"2026-02-09","ACTUAL",{"date":103,"type":101},"2012-01-11",{"date":105,"type":52},"2035-01",{"name":5,"class":6},1]